Hepatic Steatosis in Diabetic Patients

Hepatic steatosis, or fatty liver disease, is a common complication among individuals with diabetes, particularly type 2. This condition is characterized by excessive fat accumulation in liver cells, often associated with insulin resistance and obesity. Elevated insulin levels can promote lipogenesis, leading to increased fatty acid synthesis and reduced fatty acid oxidation. Hepatic steatosis can worsen insulin resistance, creating a vicious cycle that exacerbates diabetes management. Additionally, non-alcoholic fatty liver disease (NAFLD) is linked to increased cardiovascular risk and liver complications. Lifestyle modifications, including weight loss, dietary changes, and regular physical activity, are essential for managing hepatic steatosis. Medications targeting insulin sensitivity may also be beneficial. Early detection and intervention are crucial to prevent progression to more severe liver diseases, such as non-alcoholic steatohepatitis (NASH), which can have significant health implications.